These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and/or acute myeloid leukemia: a prospective analysis of 433 cases. Coleman JF; Theil KS; Tubbs RR; Cook JR Am J Clin Pathol; 2011 Jun; 135(6):915-20. PubMed ID: 21571964 [TBL] [Abstract][Full Text] [Related]
9. Human bone marrow cytogenetics: growth factors stimulate metaphases for specific lineages. Keinänen M; Bloomfield CD; Machnicki J; Griffin JD; de la Chapelle A Leukemia; 1989 Jun; 3(6):405-12. PubMed ID: 2657230 [TBL] [Abstract][Full Text] [Related]
10. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631 [TBL] [Abstract][Full Text] [Related]
12. Time-saving in biological dosimetry by using the automatic metaphase finder Metafer2. Weber J; Scheid W; Traut H Mutat Res; 1992 Aug; 272(1):31-4. PubMed ID: 1380117 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic features of juvenile chronic myelogenous leukemia. Brodeur GM; Dow LW; Williams DL Blood; 1979 May; 53(5):812-9. PubMed ID: 285733 [No Abstract] [Full Text] [Related]
14. The proportion of abnormal karyotypes in acute leukemia samples related to method of preparation. Li YS; Le Beau MM; Mick R; Rowley JD Cancer Genet Cytogenet; 1991 Mar; 52(1):93-100. PubMed ID: 2009515 [TBL] [Abstract][Full Text] [Related]
15. Pre-analytical parameters associated with unsuccessful karyotyping in myeloid neoplasm: a study of 421 samples. Santos MFM; Oliveira FCAC; Kishimoto RK; Borri D; Santos FPS; Campregher PV; Silveira PAA; Hamerschlak N; Mangueira CLP; Duarte FB; Crepaldi AH; Salvino MA; Velloso EDRP Braz J Med Biol Res; 2019 Feb; 52(2):e8194. PubMed ID: 30785480 [TBL] [Abstract][Full Text] [Related]
16. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Freireich EJ; Cork A; Stass SA; McCredie KB; Keating MJ; Estey EH; Kantarjian HM; Trujillo JM Leukemia; 1992 Jun; 6(6):500-6. PubMed ID: 1602788 [TBL] [Abstract][Full Text] [Related]
17. A myelodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16. Abbondanzo SL; Gray RG; Whang-Peng J; Jacobson RJ Arch Pathol Lab Med; 1987 Apr; 111(4):330-2. PubMed ID: 3469939 [TBL] [Abstract][Full Text] [Related]
18. An abnormal cell-line in a patient with acute granulocytic leukemia. Cytogenetic studies before and after an allogeneic marrow transplant. Littlefield LG Cancer; 1972 May; 29(5):1281-6. PubMed ID: 4553760 [No Abstract] [Full Text] [Related]
19. [Study on the role of fluorescence in situ hybridization in cytogenetic evaluation of myelodysplastic syndrome]. Qu SQ; Xu ZF; Li CW; Liu XP; Qin TJ; Zhang Y; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):839-42. PubMed ID: 23384907 [TBL] [Abstract][Full Text] [Related]
20. Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies. Hussein K; Ketterling RP; Dewald GW; Van Dyke DL; Mesa R; Hanson CA; Tefferi A Leuk Res; 2008 Oct; 32(10):1597-600. PubMed ID: 18241918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]